Cargando…
Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice
BACKGROUND: Berberine, an isoquinoline derivative alkaloid, has a wide range of pharmacological properties and is considered to have anti-inflammatory and neuroprotective effects. However, there are no reports about the effects and mechanisms of berberine in experimental autoimmune encephalomyelitis...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957444/ https://www.ncbi.nlm.nih.gov/pubmed/20976070 http://dx.doi.org/10.1371/journal.pone.0013489 |
_version_ | 1782188234879533056 |
---|---|
author | Ma, Xiaomeng Jiang, Ying Wu, Aimin Chen, Xiaohong Pi, Rongbiao Liu, Mei Liu, Yingying |
author_facet | Ma, Xiaomeng Jiang, Ying Wu, Aimin Chen, Xiaohong Pi, Rongbiao Liu, Mei Liu, Yingying |
author_sort | Ma, Xiaomeng |
collection | PubMed |
description | BACKGROUND: Berberine, an isoquinoline derivative alkaloid, has a wide range of pharmacological properties and is considered to have anti-inflammatory and neuroprotective effects. However, there are no reports about the effects and mechanisms of berberine in experimental autoimmune encephalomyelitis (EAE), an established model of multiple sclerosis (MS). METHODOLOGY/PRINCIPAL FINDINGS: Female C57 BL/6 mice immunized with myelin oligodendrocyte glycoprotein 35–55 amino acid peptide were treated with berberine at the day of disease onset and medication was administered daily until mice were sacrificed. Blood–brain barrier (BBB) permeability and the alteration of matrix metalloproteinase-2 (MMP-2, 72 kDa) and matrix metalloproteinase-9 (MMP-9, 92 kDa) in the brain and cerebrospinal fluid (CSF) of EAE mice were detected by quantitative measurement for Evan's blue (EB) content, Western blot and gelatin zymography respectively. The results showed that berberine attenuated clinical and pathological parameters of EAE, reduced the permeability of BBB, inhibited the activity and expression of MMP-9 but not MMP-2 in the CSF and brain of EAE mice. CONCLUSIONS/SIGNIFICANCE: These findings suggest that berberine is effective to attenuate the clinical severity of EAE in C57 BL/6 mice by reducing the permeability of BBB, decreasing the expression and activity of MMP-9, and decreasing the inflammatory infiltration. We think that berberine might be a potential therapeutic agent for MS. |
format | Text |
id | pubmed-2957444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-29574442010-10-25 Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice Ma, Xiaomeng Jiang, Ying Wu, Aimin Chen, Xiaohong Pi, Rongbiao Liu, Mei Liu, Yingying PLoS One Research Article BACKGROUND: Berberine, an isoquinoline derivative alkaloid, has a wide range of pharmacological properties and is considered to have anti-inflammatory and neuroprotective effects. However, there are no reports about the effects and mechanisms of berberine in experimental autoimmune encephalomyelitis (EAE), an established model of multiple sclerosis (MS). METHODOLOGY/PRINCIPAL FINDINGS: Female C57 BL/6 mice immunized with myelin oligodendrocyte glycoprotein 35–55 amino acid peptide were treated with berberine at the day of disease onset and medication was administered daily until mice were sacrificed. Blood–brain barrier (BBB) permeability and the alteration of matrix metalloproteinase-2 (MMP-2, 72 kDa) and matrix metalloproteinase-9 (MMP-9, 92 kDa) in the brain and cerebrospinal fluid (CSF) of EAE mice were detected by quantitative measurement for Evan's blue (EB) content, Western blot and gelatin zymography respectively. The results showed that berberine attenuated clinical and pathological parameters of EAE, reduced the permeability of BBB, inhibited the activity and expression of MMP-9 but not MMP-2 in the CSF and brain of EAE mice. CONCLUSIONS/SIGNIFICANCE: These findings suggest that berberine is effective to attenuate the clinical severity of EAE in C57 BL/6 mice by reducing the permeability of BBB, decreasing the expression and activity of MMP-9, and decreasing the inflammatory infiltration. We think that berberine might be a potential therapeutic agent for MS. Public Library of Science 2010-10-19 /pmc/articles/PMC2957444/ /pubmed/20976070 http://dx.doi.org/10.1371/journal.pone.0013489 Text en Ma et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Ma, Xiaomeng Jiang, Ying Wu, Aimin Chen, Xiaohong Pi, Rongbiao Liu, Mei Liu, Yingying Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title | Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title_full | Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title_fullStr | Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title_full_unstemmed | Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title_short | Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice |
title_sort | berberine attenuates experimental autoimmune encephalomyelitis in c57 bl/6 mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957444/ https://www.ncbi.nlm.nih.gov/pubmed/20976070 http://dx.doi.org/10.1371/journal.pone.0013489 |
work_keys_str_mv | AT maxiaomeng berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT jiangying berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT wuaimin berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT chenxiaohong berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT pirongbiao berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT liumei berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice AT liuyingying berberineattenuatesexperimentalautoimmuneencephalomyelitisinc57bl6mice |